Home › Steatotic Liver Disease › California › Long Beach
Steatotic Liver Disease clinical trials in Long Beach, CA
4 studies for Steatotic Liver Disease are looking for participants at sites in and around Long Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Long Beach
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RecruitingPhase 3
- Ark Clinical Research, Long Beach
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RecruitingPhase 3
- Akero Clinical Study Site, Long Beach
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RecruitingPhase 2
- Ark Clinical Research, Long Beach
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- Miami, FL16 studies
- New York City, NY16 studies
- San Diego, CA14 studies
- Houston, TX13 studies
- Austin, TX13 studies
- Richmond, VA12 studies
- Chandler, AZ10 studies
- Tucson, AZ10 studies
- St. Louis, MO9 studies
- Hialeah, FL9 studies
- Dallas, TX9 studies
Other studies in Long Beach
- Non-Small Cell Lung Cancer12 studies
- Type 2 Diabetes11 studies
- Breast Cancer9 studies
- Lung Cancer9 studies
- Alzheimer's Disease8 studies
- Prostate Cancer7 studies
- Cardiovascular Disease6 studies
- Cancer (all types)6 studies
- Obesity5 studies
- Overweight5 studies
- Dementia5 studies
- Burkitt Lymphoma4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.